Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Advanced Medical Solutions Group (CHIX:AMSl) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Advanced Medical Solutions Group's EV-to-EBIT for today is
Advanced Medical Solutions Group's current Enterprise Value is £669.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was £22.6 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Advanced Medical Solutions Group's EV-to-EBITDA for today is:
Advanced Medical Solutions Group's current Enterprise Value is £669.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was £44.0 Mil.
Advanced Medical Solutions Group's current Enterprise Value is £669.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was £228.9 Mil.
Advanced Medical Solutions Group's current Enterprise Value is £669.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was £32.6 Mil.
Advanced Medical Solutions Group's current Enterprise Value is £669.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was £20.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group Enterprise Value Related Terms
Advanced Medical Solutions Group Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group Enterprise Value Chart
CHIX:AMSL vs ISRG, BDX, MDLN: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's Enterprise Value falls into.
Advanced Medical Solutions Group Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group (CHIX:AMSL) has a Enterprise Value of £669.9 Mil as of Jun. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Advanced Medical Solutions Group and its competitors.
Is Advanced Medical Solutions Group's Enterprise Value too high?
Advanced Medical Solutions Group's current Enterprise Value is £669.9 Mil. Overall, Advanced Medical Solutions Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's Enterprise Value compare to ISRG and BDX?
Advanced Medical Solutions Group's Enterprise Value of £669.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Advanced Medical Solutions Group and its competitors. Advanced Medical Solutions Group's current Enterprise Value is £669.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.71, compared to a current price of £2.78 — trading 25.1% below its estimated fair value. The current Enterprise Value is £669.9 Mil. Advanced Medical Solutions Group's overall GF Score™ is 93/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current Enterprise Value is £669.9 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.78 is trading 25.1% below its estimated GF Value™ of £3.71.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
Enterprise Value: £669.9 Mil
GF Value™: £3.71 vs. price of £2.78 (25.1% below fair value)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group Business Description
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
93GF Score
Get the complete analysis for CHIX:AMSL
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 
